Debamestrocel

迪巴迈托赛

Report date: 2026/03/30 20:02:02

Base Information

Drug NameDebamestrocel
Drug Alias Name神经营养因子生产成人干细胞治疗 - BrainStorm Cell TherapeuticsNurOwn program oneGDNF therapyMSC-NTFNurOwn +[7] 
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived
Mechanisms of ActionNeurons stimulantsCell replacementsGlial cell line-derived neurotrophic factors stimulants +[4] 
TargetsGlial cell line-derived neurotrophic factors
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis, Chronic Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University Trust
China Registration ClassN/A

Develop Information

Active CompaniesBrainstorm Cell Therapeutics
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsMultiple Sclerosis, Chronic Progressive

Other Information

ATC CodeN/A
Related LinksN/A